MedTrace Logo

Remote Monitoring of COVID-19 Positive Outpatients

NCT04853108 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-06-18

No results posted yet for this study

Summary

This study seeks to evaluate how secondary data retrieved from remote physiological monitoring performed during routine outpatient/at-home care periods can allow for the discovery of novel physiomarkers that predict acute deterioration or hospitalization among people testing positive for Coronavirus Disease 2019 (COVID-19).

Conditions

  • Covid19

Interventions

OTHER

Remote Monitoring of COVID-19

Remote monitoring of acute COVID-19 illness included use of a Medtronic pulse oximeter, photoplethysmography (PPG), patient-reported symptoms data, static vital signs captured during the course of the clinical evaluation and various physiomarkers.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Emory University

    lead OTHER

Principal Investigators

  • Blake Anderson, MD · Emory University

Eligibility

Min Age
25 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-25
Primary Completion
2023-04-01
Completion
2023-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04853108 on ClinicalTrials.gov